Drug Regulatory Authority of Pakistan (DRAP) has granted Emergency Use Approval (EUA) to the second COVID-19 vaccine to be used in emergencies across the
Top Story
January 19, 2021
KARACHI: The Sindh government has decided to establish a ‘Covid-19 vaccine procurement fund’ with an initial capital of Rs1.5 billion for the procurement of vaccine for its frontline healthcare workers and the government has already started negotiating with private parties and manufacturers of the two vaccines, given emergency use authorization in Pakistan by the Drug Regulatory Authority of Pakistan (DRAP).
“Instead of waiting for the Covid-19 vaccine to be acquired by the federal government, we have decided to establish an emergency fund of Rs1.5 billion initially and procure vaccine for our frontline workers within a few weeks’ time. So far, we have 80,000 registered frontline workers but this can go up to 125,000 in entire Sindh who are directly dealing with the Covid-19 patients,” Sindh Health Minister Dr. Azra Pechuho told The News on Monday.
BEIJING, Jan. 19 (Xinhua) With Chinese-made vaccine shots reaching people in more countries, booming vaccine cooperation with China worldwide is injecting co
Pak Authorities Give Nod To Chinese Anti-Covid Vaccine For Emergency Use
The approval has been given for emergency use and it will pave the way for bringing the vaccine to Pakistan, says official PTI photo Outlook Web Bureau 2021-01-19T16:06:32+05:30 Pak Authorities Give Nod To Chinese Anti-Covid Vaccine For Emergency Use outlookindia.com 2021-01-19T16:07:36+05:30
Pakistan authorities on Monday approved the Chinese Sinopharm Covid-19 vaccine for emergency use as the nation witnessed a spike in the coronavirus infections.
The move comes two days after approving the emergency use of Oxford-AstraZeneca Covid-19 vaccine to curb the Covid-19 spread in the country. On Monday, Drug Regulatory Authority of Pakistan (DRAP) gave nod to the chinese Covid vaccine